Full Course Description


Fall Prevention Challenges: Real Solutions to Reduce Falls, Prevent Injuries and Limit Liability

Program Information

Outline

How to Prevent Falls Before They Occur

Fall Risk Assessment

Fall Prevention Strategies

Putting Together a Successful Fall Prevention Program

Patient Evaluation

What to do When a Patient Falls: Hands-On Evaluation

Difficult Situations

Preventing Risk and Limiting Liability

Fall Prevention Plan Development

Objectives

  1. Evaluate precipitating causes for falls so that preventative measures can be in place.
  2. Formulate a comprehensive evaluation for high fall risk patients.
  3. Analyze medications that are known to contribute in various ways to fall risks.
  4. Assess the risk for adverse patient outcome and need for urgent intervention.
  5. Determine the tools necessary for a multidisciplinary fall prevention program.
  6. Select patient-specific fall prevention interventions for a successful fall prevention plan.
  7. Evaluate the impact of common gait disorders on fall risk.

 

Copyright : 11/16/2016

Infection Control Challenges: Real Risks for Patients and Staff

OUTLINE

A summary of current recommendations from the CDC, SHEA, IDSA, APIC and the Joint Commission

Health-Care Associated Infections: Strategies to Control-Reduce-Eliminate

Program Information

Outline

National Healthcare Safety Network

Compendium Strategies: Critical Updates

CDC, APIC, SHEA, IDSA Guidelines to Control Multi-Drug Resistant Organisms

EBOLA: What’s New, What’s True & What’s Next

Emerging Infectious Diseases: Exotic to the Common

Managing Foodborne Illnesses

Vaccine Preventable Diseases are Back!

Influenza Information

Pneumococcal Disease

Updates & New Protocols for Bloodborne Pathogens

 

Objectives

  1. Plan strategies to reduce and eliminate catheter-associated urinary tract infections, surgical site infections, ventilator associated and non-ventilator-associated pneumonias and central-line-associated bloodstream infections.
  2. Assess best practices for treatment and control of multi-drug resistant microorganisms, including MRSA, Clostridium difficile, VRE, ESBL and CRE.
  3. Evaluate the newest vaccine recommendations for healthcare workers and children.
  4. Distinguish between mosquito-borne illnesses of Dengue, Chikungunya, and Zika, which may be a threat to the United States.
  5. Assess the latest treatments available for HIV/AIDS, as well as pre-exposure prophylaxis.
  6. Determine the medications available that "cure" Hepatitis C.
  7. Evaluate the current recommendations to control and treat tuberculosis.

Copyright : 10/13/2016

Program Information

Objectives

  1. Plan strategies to reduce and eliminate catheter-associated urinary tract infections, surgical site infections, ventilator associated and non-ventilator-associated pneumonias and central-line-associated bloodstream infections.
  2. Assess best practices for treatment and control of multi-drug resistant microorganisms, including MRSA, Clostridium difficile, VRE, ESBL and CRE.
  3. Evaluate the newest vaccine recommendations for healthcare workers and children.
  4. Distinguish between mosquito-borne illnesses of Dengue, Chikungunya, and Zika, which may be a threat to the United States.
  5. Assess the latest treatments available for HIV/AIDS, as well as pre-exposure prophylaxis.
  6. Determine the medications available that "cure" Hepatitis C.
  7. Evaluate the current recommendations to control and treat tuberculosis.


Program Information

Objectives

  1. Plan strategies to reduce and eliminate catheter-associated urinary tract infections, surgical site infections, ventilator associated and non-ventilator-associated pneumonias and central-line-associated bloodstream infections.
  2. Assess best practices for treatment and control of multi-drug resistant microorganisms, including MRSA, Clostridium difficile, VRE, ESBL and CRE.
  3. Evaluate the newest vaccine recommendations for healthcare workers and children.
  4. Distinguish between mosquito-borne illnesses of Dengue, Chikungunya, and Zika, which may be a threat to the United States.
  5. Assess the latest treatments available for HIV/AIDS, as well as pre-exposure prophylaxis.
  6. Determine the medications available that "cure" Hepatitis C.
  7. Evaluate the current recommendations to control and treat tuberculosis.